| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.08 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |